252 related articles for article (PubMed ID: 2458015)
1. [Analysis of the serum concentration of prostate-specific antigen as a biological marker in the evolution of disseminated prostatic cancer].
Morote Robles J; de Torres Mateos JA; Soler-Roselló A
Actas Urol Esp; 1988; 12(2):152-7. PubMed ID: 2458015
[No Abstract] [Full Text] [Related]
2. [Clinical studies on tumor markers for monitoring prostate cancer patients; the evaluation of prostate-specific antigen and comparison with prostatic acid phosphatase and gamma-seminoprotein].
Shinoda I
Nihon Gan Chiryo Gakkai Shi; 1990 Nov; 25(11):2627-39. PubMed ID: 1703555
[TBL] [Abstract][Full Text] [Related]
3. [Clinical evaluation of a prostate-specific antigen as a serum marker of prostatic cancer].
Park YC; Kiwamoto H; Nishioka T; Tsujihashi H; Mitsubayashi S; Matsuura T; Akiyama T; Kurita T; Miyamoto T
Hinyokika Kiyo; 1987 Jun; 33(6):883-8. PubMed ID: 2445188
[TBL] [Abstract][Full Text] [Related]
4. Use of gonadotropin-releasing hormone analogue in advanced prostatic cancer: 3 years clinical experience.
Matzkin H; Greenstein A; Kaver I; Braf Z
Isr J Med Sci; 1989 Jul; 25(7):388-92. PubMed ID: 2474522
[TBL] [Abstract][Full Text] [Related]
5. Serum prostatic acid phosphatase activity and prostate specific antigen when the prostate gland is enlarged.
Jenkins D; Jones RT; Clarke AM
Med Lab Sci; 1991 Apr; 48(2):161-3. PubMed ID: 1719330
[TBL] [Abstract][Full Text] [Related]
6. Review of acid phosphatase in the diagnosis and prognosis of prostatic cancers.
Rubenstein M; Guinan PD; McKiel CF; Dubin A
Clin Physiol Biochem; 1988; 6(5):241-52. PubMed ID: 2465864
[TBL] [Abstract][Full Text] [Related]
7. [New prospective diagnostic serum markers in prostatic cancer].
Mirone V; De Bellis G; Prezioso D; Sanseverino R; Iannucci F; Padulano P
Minerva Med; 1986 Mar; 77(13):503-4. PubMed ID: 2422605
[No Abstract] [Full Text] [Related]
8. Prostatic acid phosphatase and prostate-specific antigen in prostate cancer.
Kuriyama M; Loor R; Wang MC; Lee C; Killian CS; Papsidero LD; Inaji H; Nishiura T; Slack NH; Murphy GP; Chu TM
Int Adv Surg Oncol; 1982; 5():29-49. PubMed ID: 6178696
[No Abstract] [Full Text] [Related]
9. Acid phosphatase, alkaline phosphatase and prostate-specific antigen--usefulness in the diagnosis of metastatic disease and follow-up.
Bauer HW
Prog Clin Biol Res; 1988; 269():33-42. PubMed ID: 2455908
[TBL] [Abstract][Full Text] [Related]
10. Acid phosphatase, alkaline phosphatase and prostate specific antigen: which markers should we choose?
Cooper EH; Siddall JK; Newling DW; Robinson MR
Prog Clin Biol Res; 1988; 269():43-56. PubMed ID: 2455911
[No Abstract] [Full Text] [Related]
11. Prostate cancer-associated markers.
Chu TM
Immunol Ser; 1990; 53():339-56. PubMed ID: 1713065
[TBL] [Abstract][Full Text] [Related]
12. Monitoring of prostate-specific antigen during external beam radiotherapy for carcinoma of the prostate.
van Eijkeren M; van Haelst JP
Strahlenther Onkol; 1990 Aug; 166(8):557-61. PubMed ID: 1697702
[TBL] [Abstract][Full Text] [Related]
13. [The role of PSA in prostatic adenocarcinoma].
Manca GP
Minerva Med; 1990 Apr; 81(4):261-4. PubMed ID: 1692981
[TBL] [Abstract][Full Text] [Related]
14. Immunologic markers and the diagnosis of prostatic cancer.
Ban Y; Wang MC; Chu TM
Urol Clin North Am; 1984 May; 11(2):269-76. PubMed ID: 6203206
[TBL] [Abstract][Full Text] [Related]
15. Laboratory studies for the detection of carcinoma of the prostate.
Brawer MK
Urol Clin North Am; 1990 Nov; 17(4):759-68. PubMed ID: 1699341
[TBL] [Abstract][Full Text] [Related]
16. [Prostatic acid phosphatase (PAP), gamma-seminoprotein (gamma-Sm) and prostate specific antigen (PA) in prostatic cancer].
Akimoto S; Akakura K; Shimazaki J
Hinyokika Kiyo; 1988 Aug; 34(8):1389-96. PubMed ID: 2461644
[TBL] [Abstract][Full Text] [Related]
17. Tumour markers in monitoring the treatment of advanced prostate cancer.
Cooper EH; Armitage TG
Prog Clin Biol Res; 1990; 359():65-72; discussion 73-4. PubMed ID: 1704634
[No Abstract] [Full Text] [Related]
18. Cross-comparison of PSA and PAP values in a wide spectrum of prostate cancer conditions.
Tarle M
Anticancer Res; 1988; 8(4):569-72. PubMed ID: 2460018
[TBL] [Abstract][Full Text] [Related]
19. [Clinical significance of tumor markers in prostatic carcinoma--comparative study of prostatic acid phosphatase, prostate specific antigen and gamma-seminoprotein].
Yoshiki T; Okada K; Oishi K; Yoshida O
Hinyokika Kiyo; 1987 Dec; 33(12):2044-9. PubMed ID: 2452559
[TBL] [Abstract][Full Text] [Related]
20. Prostate specific acid phosphatase versus five other possible tumour markers: a comparative study in men with prostatic carcinoma.
Larson A; Fritjofsson A; Norlén BJ; Gronowitz JS; Ronquist G
Scand J Clin Lab Invest Suppl; 1985; 179():81-8. PubMed ID: 2417306
[No Abstract] [Full Text] [Related]
[Next] [New Search]